about us

Providing value to providers by simplifying the process of identifying and monitoring mental health conditions.

about us

CLINICOM shifts the mental health treatment paradigm from subjective to objective data collection

An estimated 26% of Americans ages 18 and older — about 1 in 4 adults — suffers from a diagnosable mental disorder in a given year. Many people suffer from more than one mental disorder at a given time. In particular, depressive illnesses tend to co-occur with substance abuse and anxiety disorders. With the increasing demand for faster and efficient patient care, the lack of proper assessment often results in misdiagnosis.

The initial step in any treatment plan is getting the right diagnosis—but it’s not always as accurate as one would hope. This need in the market in mental health had brought us to build an online health assessment tool to enrich patient visits by providing clinicians with precise patient information prior to meeting; eliminating misdiagnosing.

meet the team

our leadership team

Clinicom is composed of compassionate healthcare professionals, mental health innovation leaders and pioneering technology developers.

  • Nelson M. Handal, M.D

    Nelson M. Handal, M.D

    Chairman, President
  • Ignacio Handal

    Ignacio Handal

    Chief Executive Officer
  • James Riddle

    James Riddle

    Board Member
  • David Saulnier

    David Saulnier

    Chief Financial Officer
  • Jerlyn McCleod,M.D.

    Jerlyn McCleod,M.D.

    Chief Medical Officer
  • Barbara Baldwin

    Barbara Baldwin

    Director of Clinical Research
  • Marcus Couch

    Marcus Couch

    Chief Marketing Officer
  • Harry Eagens

    Harry Eagens

    Director of Corporate Development
  • Michael Gronau

    Michael Gronau

    Director of Finance
  • Adam Pearson

    Adam Pearson

    Director of Clinical Services
  • Angela Turner

    Angela Turner

    Operations Manager
  • Bill St John

    Bill St John

    Senior Advisor
Chairman, President

Nelson M. Handal, M.D

Nelson M. Handal, MD attended Medical School at the Ruprecht Karl University in Heidelberg, Germany, and graduated from Universidad Mayor de San Andres in La Paz-Bolivia, his hometown. He completed his internship and residency training in General Psychiatry at the State University of New York Health Science Center at Syracuse in Syracuse, New York. Following residency, he completed his Fellowship in Child and Adolescent Psychiatry at the University of Miami School of Medicine in Miami, Florida. At the present time he is a Clinical Faculty at the Alabama College of Osteopathic Medicine in Dothan, Alabama.

His vision to create CliniCom® was born after many years of work focused on perfecting a mental health clinical model that uses technology while implementing sensible, practical, and modern clinical practices. Developing CliniCom® for over 10 years has been for him the most challenging and expensive endeavor, but it led to an article in Forbes in 2018 after CliniCom® was used by thousands of patients around the US. Clinicom was also awarded at the Psychiatry Innovation Lab at the American Psychiatric Association. Dr. Handal was invited to testify before the United States House Committee on Veterans’ Affairs regarding innovative technologies and treatments for veterans; he spoke about CliniCom®.

For the past 20 years, Dr. Nelson M. Handal has been the Founder, Chairman, and Medical Director for Dothan Behavioral Medicine Clinic a large and modern mental health clinic. Four physicians, two nurse practitioners and thirteen therapists serve about 180 patients a day, half of whom live more than an hour away.

He is also the Founder and Medical Director of Harmonex Neuroscience Research where he participated in clinical research as a primary investigator in over 80 clinical trials for the past 14 years. He was Chief Medical Officer with NLS Pharmaceutics from Switzerland in a critical award-winning research study.

Dr. Handal has dedicated much of his career to developing and implementing technologies that elevate the quality of patient care. In the late 1980s, Dr. Handal was president of one of the first international telemedicine referral services in the world. This system was featured in Business Week.

Awards include the Heroes in the Fight Award given by Mental Health America. Excellence in Public Mental Health Award given by the National Alliance on Mental Illness (NAMI). In addition, Dr. Handal has been recognized as one of America’s Top Psychiatrists given by the Consumers’ Research Council of America. Dr. Handal has also received the Patient’s Choice Award and the Mental Health Professional of the Year Award for Alabama. He was presented with the Clinical Scholar Award conferred by the University of Miami School of Medicine. His private practice, Dothan Behavioral Medicine Clinic, has received the Best of Dothan Award in the Physicians’ category by the U.S. Local Business Association (USLBA). Dr. Handal is a Distinguished Fellow of the American Psychiatric Association and Diplomate of the American Board of Psychiatry and Neurology.

Chief Executive Officer

Ignacio Handal

Mr. Handal is a driven Senior Executive, Innovator, and Clinical Research Professional. Mr. Handal has completed a myriad FDA phase I, II, & III studies in pharmaceuticals, and devices (Class II & III) over nearly two decades. According to Globaldata.com this puts Mr. Handal in the 99.92% of all 360,382 Clinical Researchers Globally. Mr. Handal brings expert level experience in Directing Clinical Research, Site Management, Contract Negotiations, Regulatory Compliance, GCP Training, and Project Management. He has Expertise in managing multiple therapeutic areas simultaneously in multiple settings including Neuroscience, Psychiatry, Sleep Medicine, Neurology, and Ophthalmology.

As a Director of Program Management for a Global CRO, Ignacio typically managed multiple, multi-million dollar protocols at one time across indications and continents. Ignacio is experienced in managing multiple complex teams globally. He is a results-oriented leader dedicated to delivering consistently high-quality, timely results with focus on meeting key stakeholder goals and expectations. Expertise in building, cultivating, and managing, productive relationships with Pharmaceutical companies, CROs, and other Clinical Trial Vendors.

Mr. Handal has led the creation and development of two nationally recognized clinical research centers, Harmonex Neuroscience Research and Trinity Research at Eye Center South. Harmonex Neuroscience is the clinical research institute that gave birth to Clinicom at its inception. Mr. Handal Led that organization as the Director of Clinical Research and started this center de novo. Mr. Handal also teamed up with world renowned Ophthalmologist Dr. Sebastian Heersink of MIT and Wills Eye institute fame to create a world class research institute Trinity Research at the 3rd largest surgical center in the country, Eye Center South. Ignacio is an Entrepreneur and job creator. In 2008 Ignacio founded Downtown Investment Group. D.I.G. preserved and redeveloped a large portion of the historic district in his hometown of Dothan, Alabama. Preserving 50,000sqft of structures in the Historic District. With over 64+ jobs created in the city’s core and millions in revenue generated via his venues “The District” and “Saint Andrews Market” a former Ford Assembly Plant turned local Market place. Ignacio has served as a Historic preservation commissioner for the City of Dothan Alabama from 2010-2012. Ignacio is a Microbiologist by training and was the President of the College of Science and Mathematics at Auburn University, where he founded his first business at age 18 with 13 employees, AUscene Magazine, notably interviewing leading figures like Maya Angelou and Lee Corso, for his monthly publication of over 10,000 magazines from 1999-2003.

Board Member

James Riddle

In addition to providing advice to Clinicom through service on the Board of Directors; James Riddle is the Vice President for Research Services & Strategic Consulting for Advarra where he employs his extensive experience managing large operations and technology teams in the human subject protection, research administration, and regulatory fields to grow Advarra worldwide. Mr. Riddle is also a faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research (PRIM&R); a member of the CTTI Steering Committee; and leader of the SASI technology domain accreditation team.

Prior to joining Advarra, Mr. Riddle served as a leader of the human subject protection and animal care and use program at the Fred Hutchinson Cancer Research Center, one of the nation’s largest independent cancer research centers. In addition, he has served on the board of the Northwest Association for Biomedical Research (NWABR), was an AAHRPP site visitor, and was the Vice President of Operations and Director of Technology at another large central IRB. His expertise includes reengineering operational processes, systems evaluations, development and implementation of technology solutions, integration of technology solutions with operations, and management of large IRB and IACUC systems.

Mr. Riddle has a bachelor’s degree in accounting with an emphasis in computer science from Western Washington University, College of Business and Economics.

Chief Financial Officer

David Saulnier

David is the Chief Financial Officer of Clinicom Healthcare, Inc. the World’s first comprehensive digital mental health assessment tool. As CFO David is responsible for managing all financial aspects of the company including funding, financial reporting, financial planning, accounting, strategic relationships and all aspects of financial negotiations.

Prior to this David was Chief Risk Officer (CRO) for State Street Global Advisors, the third largest asset manager in the World and a subsidiary of State Street Bank (GSIFI). David oversaw all investment, trading, credit, operational, liquidity, regulatory and fiduciary risk. David chaired or was a member of the Management Risk and Capital Committee, Risk Committee, Global Investment Committee, IT Steering Committee and Global Product Committee. <

David was previously Chief Risk Officer for State Street Bank’s largest subsidiary, State Street Global Services, overseeing custody, accounting, fund administration and alternative asset servicing for $28 Trillion in assets. David served on the Boards of State Street Bank and Trust Company, NA and State Street Bank of California, NA, was Chairman of the Charitable Asset Management Committee and served on the Valuation Committee for one of Boston’s largest asset managers.

Before joining State Street David was the Head of Risk Management for Pioneer Investments where he oversaw all investment, trading, IT and Operational Risk for $70 billion in AUM. David was on numerous committees including serving as the Chair of the Trade Management Committee.

David also has experience as the Head of Counterparty Risk for Harvard Management Company where he was responsible for counterparty and credit risk for all equity, private equity, fixed income and commodity derivative investment strategies within Harvard’s endowment and its associated arbitrage portfolios. David also served as a Commercial Banker for Bank of America covering the real estate, health care and service industries.

David graduated from The Citadel Military College of SC with a BS in Business Administration and received his MBA from Baylor University’s Hankamer School of Business. David currently serves as an advisor or board member of The Citadel’s Baker School of Business and La Vida.

Chief Medical Officer

Jerlyn McCleod,M.D.

Dr. McCleod is a Board Certified Child and Adolescent Psychiatrist who has been in practice since 2003. She is the Chief Medical officer for Clinicom Healthcare Inc. She is a investigator in many clinical research studies. Dr. McCleod is the current Medical Director of Southeast Alabama Youth Services’ Diversion Center and the Boys and Girls Attention Group Homes. She is owner and founder of J.C. McCleod, MD Psychiatric, PLLC. She serves as a clinical faculty member for the Alabama College of Osteopathic Medicine supervising medical students. She also supervises nursing, counseling, and social work students in the field of psychiatry as a clinical preceptor. She has recently retired from Laurel Oaks Behavioral Health Center, an acute and residential in-patient psychiatric care for children and adolescents, where she was the Medical Director from 2009-2020. She is the former medical director of Bradford Health Clinic, an intensive out-patient center for treatment of adults and adolescents with substance dependence in Dothan, Alabama from 2006-2018.

She is a native of Chicago, Illinois and completed her Bachelor of Science Degree at Howard University in Washington, DC. She received her Medical Degree from the University of Illinois, College of Medicine. She completed her residency in General Psychiatry, and fellowship in Child and Adolescent Psychiatry both at Emory University in Atlanta, Georgia. Dr. McCleod is Board Certified in General Psychiatry as well as Child and Adolescent Psychiatry. She is licensed to practice medicine in the states of Alabama and Georgia.

Dr. McCleod is a Fellow of the American Psychiatric Association, and a member in good standing of the American Academy of Child and Adolescent Psychiatrists, the American Medical Association and the National Medical Association. She is a life member of the Global Directory of Who’s Who in American Professionals. She received the Mental Health Professional of the Year Award given by the National Alliance for the Mentally Ill (NAMI), Wiregrass in 2009. She was on the board of directors for NAMI Alabama from 2017-2019.

She served as the 12th and again as the 14th chapter President of Alpha Kappa Alpha Sorority, Incorporated, Kappa Pi Omega Chapter, and was voted as the chapter’s 2010 “Soror of the Year”. She actively volunteers in many community service projects. She’s a member of Greater Beulah Baptist Church. She is married to Don McCleod, CPA, and they have two children, Don Robert and Michelle.

Director of Clinical Research

Barbara Baldwin

Mrs. Baldwin is the Director of Clinical Research for Clinicom Healthcare, Inc. Mrs. Baldwin graduated Summa Cum Laude from Troy University with a Master’s degree in Counseling Psychology. She completed a Bachelor of Science in Psychology from Troy State University.

Mrs. Baldwin worked directly with children and adolescents at Harmonex Neuroscience Research and Laurel Oaks Behavioral Health Center.

Mrs. Baldwin began her research career at Harmonex as a research assistant, later becoming a clinical research associate responsible for coordinating a myriad of trials for nearly two decades. Since 2008 she has served as the Director of Clinical Research for Clinicom Healthcare Inc and Harmonex, and oversees the initiation, regulatory documentation, contractual negotiations, and management of all clinical studies.

Chief Marketing Officer

Marcus Couch

Director of Corporate Development

Harry Eagens

Harry Serves as the Director of Corporate Development for Clinicom. He helps develop relationships with Customers, Corporations & Family Offices. Harry brings years of finance and sales experience to the Clinicom Team.

Mr. Eagens is a driven financial markets executive that has been exposed to the incredible growth that is shaping the Global HealthCare Industry specifically via Telemedicine. More importantly, over the last several years having had the privilege of experiencing firsthand the drive, the passion & the commitment by our medical community to help others while creating tremendously successful business models. It started over 5 years ago when he was invited to prepare & present various potential financial liquidity events on behalf of a US based Biopharma drug developer. Having the unique fortune of learning from & working directly with one of the world’s leading experts for the human digestive system with the primary focus being fighting cystic fibrosis. This individual has personally saved many lives & has extended many lives by decades. Learning more & more became very exciting as the motivation grew from there. During this time frame the work flows of the Medical & the Medical Insurance Industries came to the forefront as the various sources of US Dollar & UK Sterling based funding alternatives were continuously evaluated.

Mr. Eagens recently has worked directly with the CEO & Founder of an Industry leading DNA analysis firm that has its own CLIA-certified lab. All facets of domestic & global Marketing & Sales expansion was analyzed, reviewed and documented. Multiple strategic partner relationships were developed & put in place for this initiative. Now within weeks of working with Clinicom it became clear that his professional experience to date has prepared him for the opportunities that lie ahead for the Team at Clinicom. Specifically, helping to prepare a fourteen-year-old SaaS business model as a “mature startup” now moving directly into the revenue producing mode. Combined with building the Clinicom brand awareness throughout the Medical & the HealthCare Industries. Clinicom provides efficiency tools that put the patients success first.

Harry Eagens professional business experience summary inclusive of title & responsibilities.

The NASDAQ Stock Market – Managing Director of NASDAQ Transaction Services
SPEAR, LEEDS AND KELLOGG, INC – VP SLK Capital Markets, Institutional Equity Sales Trading
FIDELITY INVESTMENTS – VP & National Sales Director, Fidelity Brokerage Technologies Group
REUTERS INFORMATION SERVICES, INC – Global Accounts Sales Manager
SHEARSON LEHMAN HUTTON, INC – VP, Futures Trading Division
PAINE WEBBER, INC – Director of the Precious Metals & the Futures Trading Desk
DEAK-PERERA, INC – Chief Precious Metals Trader & Spot FX Trader

Director of Finance

Michael Gronau

Michael Gronau is Director of Finance with Clinicom Healthcare, Inc. He is presently helping to drive the financial planning and fundraising strategy of the company by building out the financial projections, analyzing performance and suggesting appropriate funding strategies for Clinicom. Presently, Michael also serves as an elected official on the town council in his home town. On council Michael serves as Council President, Chairman of the Finance Committee, Water Commissioner and is responsible for the town’s technology infrastructure.

Prior to joining Clinicom Michael spent the last 15 years in the private investment banking world working with small boutique firms to help entrepreneurs prepare for private equity investments. Michael’s primary focus and skills were on problem solving, operations and financial modeling.

Michael began his career building a multimillion-dollar enterprise called, On-Site, a service company, that included multiple business arms and a national reach. Michael successfully grew and sold his business at a young age. One of the keys to the success of “On-Site” was the ability to build trust with customers and hosts which translated into lucrative agreements with a litany of Fortune 500 companies like Merck, Johnson & Johnson, Bristol Myers Squibb, ADP, and Merrill Lynch. Michael distinguished his company by providing excellent renowned support and service.

Director of Clinical Services

Adam Pearson

He is responsible for supporting Clinicom’s clients throughout the reimbursement process’s lifecycle along with refining future product development. Adam’s passion for evolving the patient-care experience stems from his 20+ years of clinical and non-clinical expertise. His diverse background features digital health leadership accomplishments with concentrations in tele-behavioral health and digital therapeutics reimbursement. Adam most recently served as Vice President of Clinical Services at Total Brain.

Operations Manager

Angela Turner

Mrs. Turner helps to run day to day operations at Clinicom Healthcare, Inc. Angela has been with the company for nearly a decade. She works directly with the public to educate the community about Clinicom, research and our clinical trials through community outreach, health conferences, and volunteering at local non-profit organizations.

She has also been an integral part of developing business relationship with some of the earliest Clinicom Healthcare clients. Her exemplary support and people skills have been a true asset for the company. She believes the road to success and happiness is to live by the 3P’s: Practice, Patience and Persistence.

Senior Advisor

Bill St John

Bill St John is Senior Advisor to Clinicom for Capital Strategies, Life Sciences and Management.

Bill has 25 years of experience in the biotechnology and pharmaceutical business. This experience includes founding four successful biotech firms and serving as incoming CEO for several pharmaceutical firms.

Bill has served as Managing Director of the University Funds, an early-stage venture capital firm and advisor to private equity firms. He is an expert in due diligence, technology transfer, and regular lectures on the subject.

Bill is currently a consultant to select early-stage companies and early-stage venture funds…

Mr. St. John holds a BS degree from Seattle University and an MS in Molecular Biology from The Ohio State University…

OUR HISTORY

The Clinicom Timeline

First Clinicom R&D

First online comprehensive Psychiatric assessment through Clinicom.com.

2004

Clinicom V2.0 R&D

Assessment can screen for up to 50 conditions. Clinicom used as pre-screener for clinical research. Primary clinical testing was conducted at 12 initial clinical beta testing sites.

2008

Clinicom V3.0 R&D

Additional Beta test sites added. Algorithm Builder developed to provide faster, more efficient assessments.

2011-2014

Clinicom DSM5 Update

All Clinicom algorithms updated from DSM4 to DSM5.

2013

Clinicom V4 R&D

Added additional conditions. Upgraded Encryption, HIPAA 2015-16, New R&D Beta Sites added.

2015

Clinicom V5 R&D

Alerts, Graphs, Custom Assessments, Additional R&D Beta sites added.

2016

R&D V6

Added follow up feature. Clinicom translated to Spanish, Mandarin, Portuguese and Italian.

Clinicom added to Apple Store. Clinicom research study with COPE.

2017

R&D V7

Clinicom accepted into Epic EMR app orchard. Clinicom validation study published in the May 2018 Journal of Psychiatric Research.

2018

Commercial Product Viability

After 225,000 suggested diagnosis completed, Clinicom advanced from R&D version 7 to a commercially viable release version.

2019

Clinicom V8

Clinicom V8 adds features such as Life sciences product line, Patient Triage module, Custom assessment templates, more options.

New members added to Executive team, Financial strategy team, Commercial Team and Technology team, Regulatory and Compliance work.

FDA CFR21 part 11. Full Software development life cycle documentation and testing complete.

2020

Clinicom is Ready!

Clinicom is available to help as many people as possible. Schedule a demo today and see how Clinicom can work for you and your patients! Let us show you how Clinicom's Insurance reimbursement can help grow your practice.

2021

20.6% of U.S. adults experienced mental illness in 2019 (51.5 million people). This represents 1 in 5 adults.

16.5% of U.S. youth aged 6-17 experienced a mental health disorder in 2016 (7.7 million people)

People with depression have a 40% higher risk of developing cardiovascular and metabolic diseases than the general population. People with serious mental illness are nearly twice as likely to develop these conditions.

18.4% of U.S. adults with mental illness also experienced a substance use disorder in 2019 (9.5 million individuals)

High school students with significant symptoms of depression are more than twice as likely to drop out compared to their peers.

Across the U.S. economy, serious mental illness causes $193.2 billion in lost earnings each year

Improve Diagnostic Accuracy For Better and Faster Outcomes

Request A Demo

We would love to show you how CLINICOM can help improve mental health screening in your business.

  • This field is for validation purposes and should be left unchanged.